Self-Care and Wellness: Tummy troublesSelf-care options for functional gastrointestinal disorders. Fecal transplants send ulcerative colitis into remissionPatients use enemas to administer the multi-donor mixture themselves Proton pump inhibitors could land patients in hospital Infectious gastroenteritis risk increased, Australian study shows Stelara: first interleukin inhibitor approved for use in Crohn’s disease New intravenous solution for single-dose induction, followed by subcutaneous maintenance therapy. Clinical Feature: Loperamide misuse Take steps to identify patients at risk, minimize harm and prevent misuse. Health Canada examines safety of ondansetron used off-label for nausea and vomiting of pregnancy A link with birth defects could not be confirmed or ruled out. Two new products now available without a prescription in most Canadian provinces Esomeprazole 20 mg and ibuprofen extended-release 600 mg move to nonprescription status. A mysterious abdominal pain declares itself with time PPIs linked to increased risk of chronic kidney disease and progression to end-stage renal disease Risk of adverse renal outcomes increases with duration of PPI use beyond 30 days. ASA use for the primary prevention of cardiovascular disease and colorectal cancer US task force issues updated recommendations that balance benefits and harms. First Previous 15 16 17 18 19 Next Last
